Wordt geladen...
Adjuvant imatinib for patients with high-risk gastrointestinal stromal tumors: a retrospective cohort study
The duration of adjuvant imatinib for high-risk patients with gastrointestinal stromal tumors (GISTs) is still controversial. Therefore, we retrospectively analyzed the data of high-risk patients with GISTs to investigate the appropriate duration. All 185 patients were divided into 4 groups: <1 y...
Bewaard in:
| Gepubliceerd in: | Sci Rep |
|---|---|
| Hoofdauteurs: | , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Nature Publishing Group UK
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5715066/ https://ncbi.nlm.nih.gov/pubmed/29203825 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-017-17266-5 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|